Needle Biopsy Market Expected To Reach $ 677 Million by End of 2022

Needle Biopsy Market report provides historical and forecast revenue of the market segments and sub-segments with respect to four main geographies and their countries- Americas, Europe, Asia-Pacific, and Middle East & Africa.

Pune, India – September 19, 2017 /MarketersMedia/ —

A Needle Biopsy is a procedure to extract a sample of cells from the body by inserting a needle in the appropriate sampling site. The extracted tissue is then used for laboratory testing so as to find any abnormality. The market for needle biopsy is growing due to market driving factors such as cancers, infections etc.

The Worldwide Needle Biopsy Marketinformation: by type (fine-needle aspiration biopsy, core needle biopsy, vacuum-assisted biopsy, image-guided biopsy) by utility (disposable, reusable), by applications (tumor, infection, Inflammation, others) – Global Forecast till 2023.

Global Needle Biopsy Market Synopsis:

Needle Biopsy Market Scenario:

The development of ultrasensitive imaging technologies such as Magnetic Resonance Imaging (MRI), Computed Tomography (CT) etc. are the market constraints. However the emergence of liquid biopsy is the single largest threat to the future of needle biopsy.

Get Sample PDF Illustration @ https://www.marketresearchfuture.com/sample_request/3830 .

Considering all these factors the market for Needle Biopsy is expected to reach $ 677 million by the end of 2023, this market is projected to be growing at a CAGR of ~ 5.2 % during 2017-2023.

Needle Biopsy Market Segments:

The global Needle Biopsy Market is segmented on the basis of type and applications. Based on type, the market has been segmented as fine-needle aspiration biopsy, core needle biopsy, vacuum-assisted biopsy and image-guided biopsy. Based on the utility, the market has been segmented as disposable and reusable. Based on the applications, the market has been segmented as tumor, infection, inflammation and others.

Key Players for Global Needle Biopsy Market:

Key players profiled in the report are Boston Scientific Corporation, Cook Medical, CareFusion Corporation, Hologic, Inc., and Cardinal Health, Inc., Medax, C. R. Bard, Inc., Möller Medical GmbH, Becton, Dickinson and Company, Hakko co. ltd., Kompass, Argon Medical Devices, Inc. and others.

Get Discount @ https://www.marketresearchfuture.com/check-discount/3830 .

The report for Global Needle Biopsy Market by Market Research Future comprises of extensive primary research along with the detailed analysis of qualitative as well as quantitative aspects by various industry experts, key opinion leaders to gain a deeper insight of the market and industry performance. The report gives a clear picture of the current market scenario which includes past and estimated future market size with respect to value and volume, technological advancement, macro economical and governing factors in the market. The report provides detail information about and strategies used by top key players in the industry. The report also gives a broad study of the different market segments and regions.

About US:

Market Research Future (MRFR), enable customers to unravel the complexity of various industries through Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.

Contact Info:
Name: Akash Anand
Email: akash.anand@marketresearchfuture.com
Organization: Market Research Future
Address: Pune, India
Phone: +1 646 845 9312

Source URL: https://marketersmedia.com/needle-biopsy-market-expected-to-reach-677-million-by-end-of-2022/241052

For more information, please visit https://www.marketresearchfuture.com/reports/needle-biopsy-market-3830

Source: MarketersMedia

Release ID: 241052